Key Highlights
- Revenue was USD 110.96 billion against an estimate of USD 109.90 billion and USD 103.15 billion last year.
- EPS of USD 11.68 compares with an estimate of USD 10.72; GAAP diluted EPS was USD 10.44.
- On October 5, 2026 McKesson agreed to buy a 49% stake in Option Care Health for about USD 1.4 billion.
- The quarterly Dividend was raised to USD 0.94 per share from USD 0.82 on July 21, 2026.
McKesson Corporation (NYSE:MCK) entered a definitive agreement on October 5, 2026 to acquire a 49% minority interest in Option Care Health, an independent provider of home and alternate site infusion services, for estimated cash consideration of about USD 1.4 billion. Clayton, Dubilier & Rice holds the remaining 51%. The agreement followed the fiscal second quarter ended September 30, 2026, in which Revenue was USD 110.96 billion against an estimate of USD 109.90 billion.
How the Option Care Agreement Fits the Quarter
The company targets closing in the first half of calendar year 2027, subject to customary conditions, regulatory approvals and Option Care Health Shareholder approval, and plans to account for the stake as an Equity method investment.
In early November, McKesson completed two further purchases: Precision Medicine Group, a clinical research and biopharma commercialization services provider, for cash of about USD 2.25 billion, and a controlling interest in Spectrum Vision Partners, an ophthalmology and retina management provider, for about USD 525 million. Both report within Oncology & Multispecialty from the third quarter of fiscal 2027.
Separately, the company is pursuing a separation of Medical-Surgical Solutions. On June 1, 2026, funds managed by Apollo Global Management affiliates invested about USD 1.25 billion for convertible preferred equity representing roughly 13% of that business.
Results Around the Deals
Revenue was USD 110,957 million against USD 103,150 million, an 8% increase the company stated. EPS of USD 11.68 compares with an estimate of USD 10.72, and GAAP diluted EPS attributable to McKesson was USD 10.44 against USD 8.92 a year earlier. Weighted-average diluted shares were 116.7 million against 124.4 million.
Gross profit was USD 3,956 million against USD 3,542 million, a gross Margin of 3.57% against 3.43%. Total operating expenses were USD 2,352 million against USD 2,135 million, including restructuring charges of USD 85 million. Interest expense was USD 105 million against USD 74 million, which the company attributed to higher average Loan balances. The income tax rate was 17.0%.
By segment, North American Pharmaceutical revenue was USD 91,360 million, Oncology & Multispecialty was USD 14,980 million, up 24%, Prescription Technology Solutions was USD 1,520 million and Medical-Surgical Solutions was USD 3,097 million.
Financing, Cash and Capital Returns
Cash and cash equivalents were USD 6,528 million against USD 3,975 million at March 31, 2026. Operating Cash Flow for the six months was USD 2,850 million against USD 1,502 million. Total Debt was USD 9,208 million against USD 6,526 million. The company arranged senior secured term loans at Medical-Surgical Solutions with USD 3.2 billion in net proceeds and a USD 5.0 billion unsecured Credit Facility maturing in 2031.
During the six months, McKesson returned USD 3.6 billion to shareholders through USD 3.4 billion of repurchases and USD 198 million of dividends. The board approved an additional USD 5.0 billion repurchase authorization on April 29, 2026, with USD 4.3 billion remaining at September 30.
Dates and Milestones Named
Revenue of USD 110.96 billion sits alongside GAAP diluted EPS of USD 10.44, cash of USD 6,528 million and a quarterly dividend of USD 0.94 per share.
Management named several dated items: the Option Care Health closing targeted for the first half of calendar 2027, the Precision Medicine and Spectrum Vision purchases completed in early November 2026, and a corporate restructuring program with stated charges of about USD 230 million to USD 310 million that it targets to substantially complete by the end of fiscal 2028.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...